Effective stratification of cancer patients on the basis of their molecular make-up is a key open challenge. Given the altered and heterogenous nature of cancer metabolism, we here propose to use the overall expression of central carbon metabolism as biomarker to characterize groups of patients with important characteristics, such as response to ad-hoc therapeutic strategies and survival expectancy. To this end, we here introduce the data integration framework named Metabolic Reaction Enrichment Analysis (MaREA), which strives to characterize the metabolic deregulations that distinguish cancer phenotypes, by projecting RNA-seq data onto metabolic networks, without requiring metabolic measurements. MaREA computes a score for each network reaction, based on the expression of the set of genes encoding for the associated enzyme(s). The scores are first used as features for cluster analysis and then to rank and visualize in an organized fashion the metabolic deregulations that distinguish cancer sub-types. We applied our method to recent lung and breast cancer RNA-seq datasets from The Cancer Genome Atlas and we were able to identify subgroups of patients with significant differences in survival expectancy. We show how the prognostic power of MaREA improves when an extracted and further curated core model focusing on central carbon metabolism is used rather than the genome-wide reference network. The visualization of the metabolic differences between the groups with best and worst prognosis allowed to identify and analyze key metabolic properties related to cancer aggressiveness. Some of these properties are shared across different cancer (sub) types, e.g., the up-regulation of nucleic acid and amino acid synthesis, whereas some other appear to be tumor-specific, such as the up- or down-regulation of the phosphoenolpyruvate carboxykinase reaction, which display different patterns in distinct tumor (sub)types. These results might be soon employed to deliver highly automated diagnostic and prognostic strategies for cancer patients.
Graudenzi, A., Maspero, D., Di Filippo, M., Gnugnoli, M., Isella, C., Mauri, G., et al. (2018). Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power. JOURNAL OF BIOMEDICAL INFORMATICS, 87, 37-49 [10.1016/j.jbi.2018.09.010].
|Citazione:||Graudenzi, A., Maspero, D., Di Filippo, M., Gnugnoli, M., Isella, C., Mauri, G., et al. (2018). Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power. JOURNAL OF BIOMEDICAL INFORMATICS, 87, 37-49 [10.1016/j.jbi.2018.09.010].|
|Tipo:||Articolo in rivista - Articolo scientifico|
|Carattere della pubblicazione:||Scientifica|
|Presenza di un coautore afferente ad Istituzioni straniere:||No|
|Titolo:||Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power|
|Autori:||Graudenzi, A; Maspero, D; Di Filippo, M; Gnugnoli, M; Isella, C; Mauri, G; Medico, E; Antoniotti, M; Damiani, C|
DAMIANI, CHIARA (Corresponding)
|Data di pubblicazione:||2018|
|Rivista:||JOURNAL OF BIOMEDICAL INFORMATICS|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.jbi.2018.09.010|
|Appare nelle tipologie:||01 - Articolo su rivista|